Assenagon Asset Management
MDCO

Assenagon Asset Management’s Medicines Co MDCO Stock Holding History

Assenagon Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,799
Closed -$690K – 1024
2019
Q3 		$690K Buy
+13,799
New +$550K ﹤0.01% 640
2019
Q2 		– Sell
-136,608
Closed -$3.82M – 1244
2019
Q1 		$3.82M Buy
136,608
+122,179
+847% +$2.88M 0.04% 361
2018
Q4 		$276K Buy
+14,429
New +$336K ﹤0.01% 929

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Assenagon Asset Management's MDCO Position: Q4 2019 in Review

Assenagon Asset Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 13,799 shares — an estimated $690K sold.

Assenagon Asset Management first reported a position in MDCO in Q4 2018 and held it in 3 quarters. The position peaked at $3.82M in Q1 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Assenagon Asset Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 13,799 Medicines Co shares in Q4 2019, an estimated $690K.
  • Assenagon Asset Management first reported a position in Medicines Co in Q4 2018 and held it in 3 quarters.
  • Assenagon Asset Management's Medicines Co position peaked at $3.82M in Q1 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.